Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators.

Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators.
复制标题

优化 3-氨基四氢噻吩 1,1-二氧化物,提高作为非亲电子抗氧化反应元件 (ARE) 激活剂的效力和功效。

DOI:
10.1016/j.bmcl.2023.129306
复制
发表时间:
2023
影响因子:
2.7
通讯作者:
Yun,Hwayoung
Yun,Hwayoung
中科院分区:
医学4区
文献类型:
--
作者:
Jo,Jeyun;Kim,Jisu;Ibrahim,Lara;Kumar,Manoj;Iaconelli,Jonathan;Tran,CongSo;Moon,HyungRyong;Jung,Yunjin;Wiseman,RLuke;Lairson,LukeL;Chatterjee,ArnabK;Bollong,MichaelJ;Yun,Hwayoung

文献摘要

参考文献

相似文献

用非亲电子小分子激活 NRF2 驱动的转录是治疗氧化应激和炎症相关疾病状态的一种有吸引力的策略。在这项研究中,我们描述了一项优化先前确定的基于双砜的非亲电 ARE 激活剂的效力和功效的活动2。这项工作确定了有效的类似物 17(一种在 IMR32 细胞中具有非细胞毒性特征的化合物),以及 ARE 激活剂 18 和 22(具有改善的细胞效力的类似物)。 硅药物相似性预测表明,优化的双砜 17、18 和 22 可能具有药理学用途。
Activating NRF2-driven transcription with non-electrophilic small molecules represents an attractive strategy to therapeutically target disease states associated with oxidative stress and inflammation. In this study, we describe a campaign to optimize the potency and efficacy of a previously identified bis-sulfone based non-electrophilic ARE activator2. This work identifies the efficacious analog17, a compound with a non-cytotoxic profile in IMR32 cells, as well as ARE activators18and22,analogs with improved cellular potency.In silicodrug-likeness prediction suggested the optimized bis-sulfones17,18, and22will likely be of pharmacological utility.
DOI: 10.1182/blood.v57.2.267.bloodjournal572267
发表时间: 1981-02
期刊: Blood
影响因子: 20.3
作者:
K. Sullivan;H. Shulman;R. Storb;Weiden Pl;R. Witherspoon;G. McDonald;M. Schubert;K. Atkinson;Thomas Ed
通讯作者: K. Sullivan;H. Shulman;R. Storb;Weiden Pl;R. Witherspoon;G. McDonald;M. Schubert;K. Atkinson;Thomas Ed
DOI: --
发表时间: 1977
影响因子: 158.5
作者:
R. Storb;R. Prentice;E. Thomas
通讯作者: E. Thomas
骨髓移植受者环孢素相关的肾功能障碍。
DOI: --
发表时间: 1985
影响因子: 0.9
作者:
Yee,GC;Kennedy,MS;Deeg,HJ;Leonard,TM;Thomas,ED;Storb,R
通讯作者: Storb,R
DOI: 10.1056/nejm198202183060703
发表时间: 1982-01-01
影响因子: 158.5
作者:
RAMSAY, NKC;KERSEY, JH;NESBIT, ME
通讯作者: NESBIT, ME
对 65 例输血再生障碍性贫血患者进行有或无供体血沉棕黄层细胞的骨髓移植。
DOI: --
发表时间: 1982
期刊: Blood
影响因子: 20.3
作者:
Rainer;Storb;Kristine;C.;Doney;E.;D.;Thomas;Fred;Appelbaum;Dean;Buckner;Reginald;A.;CIift;H.;Joachim;Deeg;Brian;W.;Goodell;Robert;Hackman;John;Hansen;Jean;Sanders;Keith;Sullivan;Paul;L.;Weiden;P.;Witherspoon
通讯作者: Witherspoon